No significant improvements in PFS were observed in the trabectedin arms as compared to the doxorubicin arm ( T@h versus doxorubicin : hazard ratio ( HR ) @ , @ % confidence interval ( CI ) @-@ @ , P = @ ; T@h versus doxorubicin : HR @ , @ % CI @-@ @ , P = @ ) .